COMP <GO>
TWST vs PCVX // DIVIDEND YIELD & FCF PAYOUT SAFETY
Twist Bioscience Corporation (NASDAQ) VS. Vaxcyte Inc. (NASDAQ) • 15-METRIC TALLY: TWST 7
— PCVX 4
■ METRIC PARITY
LAST: $129.04 (-15.54%) • MKT CAP: $10.13B
dividend-safety
0.00%
LAST: $60.62 (-2.27%) • MKT CAP: $9.76B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TWST VS. PCVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TWST | PCVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 94.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.70% | -27.60% | +15.90 | TWST | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.66% | -6.79% | +6.13 | TWST | /fcf-yield <GO> |
| Operating Margin | -4.20% | -33.50% | +29.30 | TWST | /operating-margins <GO> |
| Net Profit Margin | -2.40% | 0.00% | -2.40 | PCVX | /net-margins <GO> |
| Revenue Growth (YoY) | 16.50% | 19.80% | -3.30 | PCVX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 18.11 | +7.89 | TWST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | TWST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.4 | 48.7 | -0.30 | PCVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 1.07 | -0.09 | PCVX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 23.0x | -2.00 | TWST | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.13B | $9.76B | $366.6M | TWST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TWST REV | PCVX REV | TWST GROSS % | PCVX GROSS % | TWST FCF | PCVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $381.5M | $2.59B | — | — | -$75.6M | -$669.3M |
| FY 2024 | $618.3M | $1.59B | — | — | -$69.2M | -$475.1M |
| FY 2023 | $608.0M | $1.31B | — | — | -$142.5M | -$296.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TWST // BETA 0.98
PCVX // BETA 1.07